|
2012
|
Invention
|
Oxindole compounds.
The invention provides compounds that inhibit PIM kinases and Flt3 kinase, a... |
|
2011
|
Invention
|
Deuterated serine-threonine protein kinase modulators. The present invention provides deuterated ... |
|
2010
|
Invention
|
Polymorphs and salts of a kinase inhibitor. The present invention relates to novel crystalline po... |
|
|
Invention
|
Pyrazolopyrimidines and related heterocycles as ck2 inhibitors. The invention provides compounds ... |
|
|
Invention
|
Biomarkers for predicting the sensitivity and response of protein kinase ck2-mediated diseases to... |
|
|
Invention
|
Novel tricyclic protein kinase modulators. The invention provides compounds that inhibit CK2 and/... |
|
|
Invention
|
Tricyclic compounds and pharmaceutical uses thereof. The invention provides compounds that inhibi... |
|
|
Invention
|
Pharmaceutically useful heterocycle-substituted lactams. The invention provides compounds that in... |
|
|
Invention
|
Condensed quinolines as protein kinase modulators. The invention relates in part to molecules of ... |
|
|
Invention
|
Combination therapies with ck2 modulators. The present application is generally directed to compo... |
|
|
Invention
|
Rhodanines and related heterocycles as kinase inhibitors. The invention provides compounds that i... |
|
|
Invention
|
Pyrazolopyrimidines and related heterocycles as kinase inhibitors. The invention provides compoun... |
|
|
Invention
|
Novel protein kinase modulators. The invention provides compounds that inhibit selected kinases (... |
|
|
Invention
|
Method of treating disorders associated with protein kinase ck2 activity. The invention provides ... |
|
2009
|
Invention
|
Oxindole compounds. The invention provides compounds that inhibit PIM kinases and Flt3 kinase, an... |
|
|
Invention
|
Combination therapies for neoplastic disorders. The present application is generally directed to ... |
|
|
Invention
|
Protein kinase modulators. The invention relates in part to molecules having certain biological a... |
|
2008
|
Invention
|
Quinolone analogs and methods related thereto. The present invention provides novel quinolone com... |
|
|
Invention
|
Therapeutic kinase modulators. The invention relates in part to molecules having certain biologic... |
|
|
Invention
|
Quinobenzoxazine analogs and methods of using thereof.
The present invention relates to quinoben... |
|
|
Invention
|
Methods for treating ophthalmic disorders. The invention relates in part to methods for treating ... |
|
|
Invention
|
Methods for treating aberrant cell proliferation disorders. The invention relates in part to meth... |
|
|
Invention
|
Methods for treating aberrant cell proliferation disorders.
The invention relates in part to met... |
|
|
Invention
|
Methods for treating ophthalmic disorders.
The invention relates in part to methods for treating... |
|
|
Invention
|
Hydrazide compounds and uses thereof. This application relates to certain novel polycyclic compou... |
|
|
Invention
|
Human ribosomal dna (rdna) and ribosomal rna (rrna) nucleic acids and uses thereof.
Provided her... |
|
|
Invention
|
Substituted quinobenzoxazine analogs. The present invention relates to quinobenzoxazines analogs ... |
|
2007
|
Invention
|
Methods for determining therapeutic efficacy of quinolone analogs. Provided herein are methods fo... |
|
|
Invention
|
Rapid analysis of oral bioavailability.
Provided herein are procedures for rapidly determining o... |
|
|
Invention
|
Drug biovailability screens. Provided herein are methods for ranking compounds by predicted bioav... |
|
|
Invention
|
Serine-threonine protein kinase and parp modulators. The invention relates in part to molecules h... |
|
|
Invention
|
Pyridinone analogs as cell proliferation inhibitors. The present invention provides pyridinone an... |
|
|
Invention
|
Quinolone analogs derivatized with sulfonic acid, sulfonate or sulfonamide. The present invention... |
|
|
Invention
|
Drug administration methods.
Provided herein are methods for administering an efficacious amount... |
|
|
Invention
|
Drug administration methods. Provided herein are methods for administering an efficacious amount ... |
|
|
Invention
|
Tetracyclic imidazole analogs. The present invention provides tetracyclic imidazole analogs which... |
|
|
Invention
|
Substituted quinobenzoxazine analogs.
The present invention relates to quinobenzoxazines analogs... |
|
2006
|
Invention
|
Methods for targeting quadruplex sequences.
Provided are quadruplex nucleotide sequences and met... |
|
|
Invention
|
Methods for targeting quadruplex sequences |
|
|
Invention
|
Human ribosomal dna(rdna) and ribosomal rna (rrna) nucleic acids and uses thereof. Provided herei... |
|
|
Invention
|
Methods of preparing quinolone analogs. The present invention relates to the preparation of compo... |
|
|
Invention
|
Max quadruplex nucleic acids and uses thereof.
The MAX regulatory region contains a functional q... |
|
|
Invention
|
Substituted quinobenzoxazine analogs. The present invention relates to methods for ameliorating a... |
|
|
Invention
|
Mcl-1 quadruplex nucleic acids and uses thereof.
A biologically significant quadruplex structure... |
|
|
Invention
|
Quinobenzoxazine analogs and compositions. The present invention relates to quinobenzoxazines ana... |
|
2005
|
Invention
|
Psorospermin and analogues.
Methods of making chiral psorospermin or its analogues and/or interm... |
|
|
Invention
|
Heterocyclic substituted 1,4-dihydro-4-oxo-1,8-naphthpyridine analogs.
The present invention re... |
